Self-hypnosis training for managing chronic pain
Self-hypnosis Training in Chronic Pain Management: A Qualitative Exploratory Study of Patients Practicing Self-hypnosis
This study is testing a self-hypnosis training program to see if it can help people with chronic pain feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ciusss de L'Est de l'Île de Montréal Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT06279650 on ClinicalTrials.gov |
What this trial studies
This pilot study evaluates the effectiveness of a self-hypnosis training program designed for chronic pain management. Participants will engage in self-hypnosis practices within groups, with the primary focus on assessing changes in pain levels over a 3-month and 6-month follow-up period. Secondary objectives include measuring the impact of the intervention on functional pain effects, anxiety-depression scores, and overall quality of life. The study will involve 60 patients from pain clinics and will be conducted at the Centre de Recherche de l'Hôpital Maisonneuve-Rosemont in Montreal, Quebec.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have chronic pain lasting at least 3 months and can participate in a telepractice intervention.
Not a fit: Patients with severe cognitive impairments or current psychiatric instability may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce chronic pain and improve the quality of life for patients.
How similar studies have performed: While self-hypnosis has been explored in other contexts, this specific application for chronic pain management is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion criteria were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews. * be 18 years of age or older; * have received one of the above diagnoses, confirmed by medical record review or physician confirmation; * report pain that has been present for at least 3 months; * have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline; * be able to read, speak and understand French; * have Internet access and be able to participate in a telepractice intervention group and complete online questionnaires. Exclusion Criteria: * have deafness and/or severe cognitive impairment that may impair communication; * have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
Where this trial is running
Montreal, Quebec
- 5415 Bd de l'Assomption — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Study coordinator: David Ogez
- Email: david.ogez@umontreal.ca
- Phone: 514 609-4391
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.